andexanet alfa

andexanet alfa
Trade Name
Orphan Indication For reversing the anticoagulant effect of direct or indirect factor Xa inhibitors in patients experiencing a serious uncontrolled bleeding event or who require urgent or emergent surgery
USA Market Approval USA
USA Designation Date 2015-02-23 00:00:00
Sponsor Portola Pharmaceuticals;270 East Grand Avenue;South San Francisco, California, 94080